Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARB - SOLIGENIX, INC. | f10k2019ex32-2_soligenix.htm |
| EX-32.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARB - SOLIGENIX, INC. | f10k2019ex32-1_soligenix.htm |
| EX-31.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RULE 13(A) - SOLIGENIX, INC. | f10k2019ex31-2_soligenix.htm |
| EX-31.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO EXCHANGE ACT RULE 13(A) - SOLIGENIX, INC. | f10k2019ex31-1_soligenix.htm |
| EX-23.1 - CONSENT OF EISNERAMPER LLP - SOLIGENIX, INC. | f10k2019ex23-1_soligenix.htm |
| EX-4.6 - DESCRIPTION OF SECURITIES. - SOLIGENIX, INC. | f10k2019ex4-6_soligenix.htm |
| 10-K - ANNUAL REPORT - SOLIGENIX, INC. | f10k2019_soligenixinc.htm |
EXHIBIT 21.1
SUBSIDIARIES OF SOLIGENIX, INC.
The following represents a list of Soligenix, Inc.’s subsidiaries:
| Name | Ownership | State of Incorporation | ||
| Enteron Pharmaceuticals, Inc. | 100.00 | % | Delaware | |
| Orasomal Technologies Inc. | 75.30 | % | Delaware | |
| DOR BioDefense Corp. | 100.00 | % | Delaware | |
| Soligenix BioPharma Canada Incorporated | 100.00 | % | Canada | |
| Soligenix UK Limited | 100.00 | % | United Kingdom |